Factor V Leiden thrombophilia, formed by a genetic mutation, slows the body’s anticoagulation response to clot formation. First described in 1994, factor V Leiden mutation has been identified as a contributing risk factor for venous thromboembolism. Although venous thromboembolism is considered rare in the pediatric population, Factor V Leiden has implications for certain at-risk pediatric patients.
Akman, I., Ozek, E., Yilmaz, Y., & Bilgen, H. (2003). Cerebral infarcts in full term neonates. Turkish Journal of Pediatrics, 45(2), 141-147.
2.
Andrew, M., David, M., Adams, M., Ali, K., Anderson, R., Barnard, D., et al. (1994). Venous thromboembolic complications (VTE) in children: First analyses of the Canadian Registry of VTE. Blood, 83(5), 1251-1257.
3.
Anton, N., & Massicotte, M. P. (2001). Venous thromboembolism in pediatrics. Seminars in Vascular Medicine, 1(1), 111-122.
4.
Baglin, C., Brown, K., Luddington, R., & Baglin, T. (1998). Risk of recurrent venous thromboembolism in patients with the Factor V Leiden (FVR506Q) mutation: Effect of warfarin and prediction by precipitating factors. East Anglian Thrombophilia Study Group. British Journal of Haematology, 100(4), 764-768.
5.
Baglin, T., Baglin, C., Brown, K., & Luddington, R. (1998). Anti-coagulation may be beneficial in high risk Factor V Leiden carriers. British Medical Journal, 317(7155), 416-416.
6.
Bertina, R. M., Koeleman, B. P., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., et al. (1994). Mutation in blood coagulation Factor V associated with resistance to activated protein C. Nature, 369(6475), 64-67.
7.
Chan, A. K., & deVeber, G. (2000). Prothrombotic disorders and ischemic stroke in children. Seminars in Pediatric Neurology, 7(4), 301-308.
8.
Dahlback, B. (2003). The discovery of activated protein C resistance. Journal of Thrombolysis and Haemostasis, 1(1), 3-9.
9.
David, M., & Andrew, M. (1993). Venous thromboembolic complications in children. Journal of Pediatrics, 123(3), 337-346.
10.
De Stefano, V., Chiusolo, P., Paciaroni, K., & Leone, G. (1998). Epidemiology of Factor V Leiden: Clinical implications. Seminars in Thrombolysis and Hemostasis, 24(4), 367-379.
11.
Dobell, A. R., Trusler, G. A., Smallhorn, J. F., & Williams, W. G. (1986). Atrial thrombi after the Fontan operation. Annals of Thoracic Surgery, 42(6), 664-667.
12.
Donahue, B. S. (2004). Factor V Leiden and perioperative risk. Anesthesia and Analgesia, 98(6), 1623-1634 (table of contents).
13.
Dowling, N. F., Austin, H., Dilley, A., Whitsett, C., Evatt, B. L., & Hooper, W. C. (2003). The epidemiology of venous thromboembolism in Caucasians and African-Americans: The GATE Study. Journal of Thrombolysis and Haemostasis, 1(1), 80-87.
14.
Ganesan, V., Chong, W. K., Cox, T. C., Chawda, S. J., Prengler, M., & Kirkham, F. J. (2002). Posterior circulation stroke in childhood: Risk factors and recurrence. Neurology, 59(10), 1552-1556.
15.
Gathof, B. S., Picker, S. M., & Rojo, J. (2004). Epidemiology, etiology and diagnosis of venous thrombosis. European Journal of Medical Research, 9(3), 95-103.
16.
Grody, W. W., Griffin, J. H., Taylor, A. K., Korf, B. R., & Heit, J. A. (2001). American College of Medical Genetics consensus statement on Factor V Leiden mutation testing. Genetics Medicine, 3(2), 139-148.
17.
Gurgey, A., & Aslan, D. (2001). Outcome of noncatheter-related thrombosis in children: Influence of underlying or coexisting factors. Journal of Pediatrics Hematology/Oncology, 23(3), 159-164.
18.
Gurgey, A., Ozyurek, E., Gumruk, F., Celiker, A., Ozkutlu, S., Ozer, S., et al. (2003). Thrombosis in children with cardiac pathology: Frequency of Factor V Leiden and prothrombin G20210A mutations. Pediatric Cardiology, 24(3), 244-248.
19.
Hirsch, D. R., Mikkola, K. M., Marks, P. W., Fox, E. A., Dorfman, D. M., Ewenstein, B. M., et al. (1996). Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: Prevalence of Factor V Leiden. American Heart Journal, 131(6), 1145-1148.
20.
Jahangiri, M., Shore, D., Kakkar, V., Lincoln, C., & Shinebourne, E. (1997). Coagulation factor abnormalities after the Fontan procedure and its modifications. Journal of Thoracic and Cardiovascular Surgery, 113(6), 989-992; discussion 992-993.
21.
Juul, K., Tybjaerg-Hansen, A., Schnohr, P., & Nordestgaard, B. G. (2004). Factor V Leiden and the risk for venous thromboembolism in the adult Danish population. Annals of Internal Medicine, 140(5), 330-337.
22.
Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., et al. (1999). A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine, 340(12), 901-907.
23.
Lensen, R. P., Bertina, R. M., de Ronde, H., Vandenbroucke, J. P., & Rosendaal, F. R. (2000). Venous thrombotic risk in family members of unselected individuals with Factor V Leiden. Thrombosis and Haemostasis, 83(6), 817-821.
24.
Lindmarker, P., Schulman, S., Sten-Linder, M., Wiman, B., Egberg, N., & Johnsson, H. (1999). The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation Factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation. Thrombosis and Haemostasis, 81(5), 684-689.
25.
Mandala, M., Curigliano, G., Bucciarelli, P., Ferretti, G., Mannucci, P. M., Colleoni, M., et al. (2004). Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter. Annals of Oncology, 15(4), 590-593.
26.
Martinelli, I. (2003). Pros and cons of thrombophilia testing: pros. Journal of Thrombolysis and Haemostasis, 1(3), 410-411.
27.
Middendorf, K., Gohring, P., Huehns, T. Y., Seidel, D., Steinbeck, G., & Nikol, S. (2004). Prevalence of resistance against activated protein C resulting from Factor V Leiden is significantly increased in myocardial infarction: Investigation of 507 patients with myocardial infarction. American Heart Journal, 147(5), 897-904.
28.
Monagle, P., & Andrew, M. (1998). Coagulation abnormalities after Fontan procedures. Journal of Thoracic and Cardiovascular Surgery, 115(3), 732-733.
29.
Monagle, P., Cochrane, A., McCrindle, B., Benson, L., Williams, W., & Andrew, M. (1998). Thromboembolic complications after fontan procedures—The role of prophylactic anticoagulation. Journal of Thoracic and Cardiovascular Surgery, 115(3), 493-498.
30.
Nagy, V., Facsko, A., Takacs, L., Balazs, E., Berta, A., Balogh, I., et al. (2004). Activated protein C resistance in anterior ischaemic optic neuropathy. Acta Ophthalmologica Scandinavica, 82(2), 140-143.
31.
Nowak-Gottl, U., Dubbers, A., Kececioglu, D., Koch, H. G., Kotthoff, S., Runde, J., et al. (1997). Factor V Leiden, protein C, and lipoprotein (a) in catheter-related thrombosis in childhood: A prospective study. Journal of Pediatrics, 131(4), 608-612.
32.
Nowak-Gottl, U., Junker, R., Kreuz, W., von Eckardstein, A., Kosch, A., Nohe, N., et al. (2001). Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood, 97(4), 858-862.
33.
Nowak-Gottl, U., Schneppenheim, R., & Vielhaber, H. (1997). APC resistance in childhood thromboembolism: Diagnosis and clinical aspects. Seminars in Thrombolysis and Hemostasis, 23(3), 253-258.
34.
Ong, B. C., Zimmerman, A. A., Zappulla, D. C., Neufeld, E. J., & Burrows, F. A. (1998). Prevalence of Factor V Leiden in a population of patients with congenital heart disease. Canadian Journal of Anaesthesia, 45(12), 1176-1180.
35.
Orenstein, S. R. (1999). Pediatric inflammatory bowel disease. Current Gastroenterology Reports, 1(3), 220-222.
36.
Ozawa, T., Niiya, K., & Sakuragawa, N. (1996). Absence of Factor V Leiden in the Japanese. Thrombosis Research, 81(5), 595-596.
37.
Ozbek, U., & Tangun, Y. (1996). Frequency of Factor V Leiden in Turkey. International Journal of Hematology, 64(3-4), 291-292.
38.
Ozyurek, E., Besbas, N., Aslan, D., & Gurgey, A. (2003). Trauma as a risk factor for thrombosis in children: A report of three cases. Turkish Journal of Pediatrics, 45(2), 167-169.
39.
Rees, D. C., Chapman, N. H., Webster, M. T., Guerreiro, J. F., Rochette, J., & Clegg, J. B. (1999). Born to clot: the European burden. British Journal of Haematology, 105(2), 564-566.
40.
Rees, D. C., Cox, M., & Clegg, J. B. (1995). World distribution of Factor V Leiden. Lancet, 346(8983), 1133-1134.
41.
Ridker, P. M., Hennekens, C. H., Selhub, J., Miletich, J. P., Malinow, M. R., & Stampfer, M. J. (1997). Interrelation of hyperhomocyst(e)inemia, Factor V Leiden, and risk of future venous thromboembolism. Circulation, 95(7), 1777-1782.
42.
Schlegel, N. (1997). Thromboembolic risks and complications in nephrotic children. Seminars in Thrombolysis and Hemostasis, 23(3), 271-280.
43.
Schulman, S., Rhedin, A. S., Lindmarker, P., Carlsson, A., Larfars, G., Nicol, P., et al. (1995). A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. New England Journal of Medicine, 332(25), 1661-1665.
44.
Simioni, P., Prandoni, P., Lensing, A. W., Scudeller, A., Sardella, C., Prins, M. H., et al. (1997). The risk of recurrent venous thromboembolism in patients with an Arg506—>Gln mutation in the gene for Factor V (Factor V Leiden). New England Journal of Medicine, 336(6), 399-403.
45.
Simsic, J. M., Uber, W. E., Lazarchick, J., & Bradley, S. M. (2002). Systemic-to-pulmonary artery shunt thrombosis in a neonate with Factor V Leiden mutation. Annals of Thoracic Surgery, 74(6), 2179-2181.
46.
Svensson, P. J., & Dahlback, B. (1994). Resistance to activated protein C as a basis for venous thrombosis. New England Journal of Medicine, 330(8), 517-522.
47.
Sweeney, J. D., Blair, A. J., Dupuis, M. P., King, T. C., & Moulton, A. L. (1997). Aprotinin, cardiac surgery, and Factor V Leiden. Transfusion, 37(11-12), 1173-1178.
48.
Tormene, D., Simioni, P., Prandoni, P., Franz, F., Zerbinati, P., Tognin, G., et al. (2002). The incidence of venous thromboembolism in thrombophilic children: A prospective cohort study. Blood, 100(7), 2403-2405.
